Arcus Biosciences: A Excessive-Threat Hypothesis With Close to-Time period Catalysts
This text was written byObserveIB's Ideas is owned and operated by a inventory market fanatic, who has written for Searching ...
Saturday, May 10, 2025
Tag: Biosciences
Becton Dickinson goals to separate off biosciences unit, as Starboard calls for a similar
Pavlo Gonchar | Sopa Pictures | Lightrocket | Getty PicturesFirm: Becton Dickinson and Co (BDX)Enterprise: Becton Dickinson develops, manufactures and ...
Oppenheimer cuts Spruce Biosciences shares target cut to $4 on trial results By Investing.com
© Reuters. On Thursday, Oppenheimer adjusted its outlook on Spruce Biosciences, Inc. (NASDAQ:SPRB), reducing the price target to $4 for ...
Should You Buy Pacific Biosciences Stock Now?
Earlier this month we dissected the ongoing battle between investor activist Carl Icahn and the second-biggest holding in our Nanalyze ...
Cytek Biosciences, Inc. (CTKB) Q1 2023 Earnings Call Transcript
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Paul Goodson - ...
Arcus Biosciences: Anti-TIGIT Therapy On Track With ARC-7 Results (NYSE:RCUS)
AzmanJaka/E+ via Getty Images Arcus Biosciences (NYSE:RCUS) is a biopharmaceutical company specializing in cancer therapeutics that are operating at the ...
Selecta Biosciences Stock: Mind the Dilution
Anyone who remembers the days of Flamel and Sky Pharma knows that the promise of nano drug delivery never really ...
Pacific Biosciences Inventory Falls Whereas Income Rises
One in every of Warren Buffett’s many notable quotes is that “in case you’ve been taking part in poker for ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.